DLA Taps Valneva for $70M Vaccine Dev’t Contract

Biotechnology company Valneva USA has landed a one-year, $70M firm-fixed-price contract from the Defense Logistics Agency to develop a vaccine against Japanese encephalitis virus.

The vaccine is intended for members of the U.S. Air Force, Army, Marine Corps and Navy, the Department of Defense said Tuesday.

Contract work is scheduled to run through Jan. 14, 2020 and will take place in Maryland and the U.K.

The Centers for Disease Control and Prevention said that JE virus is transmitted by mosquitoes and may cause death.

Gaithersburg, Md.-based Valneva aims to discover, develop and commercialize vaccines to treat infectious diseases.

You may also be interested in...

IDS International

IDS Buys GovSource, DECO in Military Training Market Push

Arlington, Virginia-based IDS International has purchased GovSource and DECO for an undisclosed sum in a move to create a global provider of training support services to the military sector.

Gregory Slavonic Board vice chairman CRC

Navy Vet Gregory Slavonic Named Vice Chairman of CRC Surface Technologies’ Board

Gregory Slavonic, a retired U.S. Navy rear admiral, has been named vice chairman of the board of directors at single-source metal finishing service provider CRC Surface Technologies.

N2WS

N2WS’ Cloud Backup Tech Added to DLT Public Sector Offerings

N2W Software has teamed up with Tech Data's DLT Solutions subsidiary to offer a data backup and recovery product to government agencies that manage workload in an Amazon Web Services cloud environment.